NUCB2 抗体

Chen, Cao, Chang, Ma, Gao, Tong, Li, Han, Yi: "Increasing hypothalamic nucleobindin 2 levels and decreasing hypothalamic inflammation in obese male mice via diet and exercise alleviate obesity-associated hypogonadism." in: Neuropeptides, Vol. 74, pp. 34-43, (2019) (PubMed).

Kaya, Yilmaz, Bayram, Gunduz, Kizilay, Ozturk: "Effects of cannabinoid modulation on hypothalamic nesfatin-1 and insulin resistance." in: The Chinese journal of physiology, Vol. 62, Issue 5, pp. 182-187, (2019) (PubMed).

Zhang, Lu, Feng, Wang, Tang, Cheng, Du, Wang, Li, Sun: "Nesfatin-1 promotes VSMC migration and neointimal hyperplasia by upregulating matrix metalloproteinases and downregulating PPARγ." in: Biomedicine & pharmacotherapy, Vol. 102, pp. 711-717, (2018) (PubMed).

Lu, Wang, Tang, Cheng, Du, Wang, Feng, Li, Cai, Qiu, Sun: "Nesfatin-1 functions as a switch for phenotype transformation and proliferation of VSMCs in hypertensive vascular remodeling." in: Biochimica et biophysica acta. Molecular basis of disease, Vol. 1864, Issue 6 Pt A, pp. 2154-2168, (2018) (PubMed).

Jia, Li, Li, Wu, Xie, Lin: "Role of nesfatin-1 in a rat model of visceral hypersensitivity." in: World journal of gastroenterology : WJG, Vol. 19, Issue 22, pp. 3487-93, (2013) (PubMed).

Stadler, Hjelmare, Neumann, Jonasson, Pepperkok, Uhlén, Lundberg: "Systematic validation of antibody binding and protein subcellular localization using siRNA and confocal microscopy." in: Journal of proteomics, Vol. 75, Issue 7, pp. 2236-51, (2012) (PubMed).

Luo, Grass, Diamandis: "The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in the breast carcinoma cell line BT-474." in: Anticancer research, Vol. 20, Issue 2A, pp. 981-6, (2000) (PubMed).

Goyal, Smith, Cowan, Wazer, Lee, Band: "The role for NES1 serine protease as a novel tumor suppressor." in: Cancer research, Vol. 58, Issue 21, pp. 4782-6, (1998) (PubMed).

Liu, Wazer, Watanabe, Band: "Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression." in: Cancer research, Vol. 56, Issue 14, pp. 3371-9, (1996) (PubMed).